Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study
By Cees van Nieuwkoop, Tobias N Bonten, Jan W van't Wout, Ed J Kuijper, Geert H Groeneveld, Martin J Becker, Ted Koster, G Hanke Wattel-Louis, Nathalie M Delfos, Hans C Ablij, Eliane MS Leyten and Jaap T van Dissel
(2005). Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics
(2007). AM: Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients.
(1998). Andremont A: Earlier positivity of central-venous- versus peripheralblood cultures is highly predictive of catheter-related sepsis.
(2006). Are blood cultures necessary in the management of women with complicated pyelonephritis?
(2010). Assendelft WJ, van Dissel JT: Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment.
(1992). Bacteremic and non-bacteremic febrile urinary tract infection–a review of 168 hospital-treated patients. Infection
(2003). Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis
(2006). Chung HM: The clinical impact of bacteremia in complicated acute pyelonephritis.
(2003). Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med
(2000). Dissel JT: Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis
(2004). Gaido L: Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis
(1996). GL: Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis.
(2010). Group: Can Creactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect
(2009). Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department.
(2001). Increasing blood culture use at US hospital emergency department visits,
(2008). Investigators: Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med
(2007). JA: Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med
(2002). Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis
(2007). Microbial and clinical determinants of time-topositivity in patients with bacteraemia. Clin Microbiol Infect
(2007). MP: Detection of bloodstream infections in adults: how many blood cultures are needed?
(2003). PD: Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol
(2009). ProHOSP Study Group: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA
(2010). ProHOSP Study Group: Procalcitonin levels Predict Bacteremia in Patients with community-acquired Pneumonia: A prospective cohort trial. Chest
(2010). Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis
(2007). Roupie E: A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol
(1997). Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis.
(1992). Thomson RB: Difficulty in predicting bacteremia in elderly emergency patients. Ann Emerg Med
(2007). Trampuz A: Circulating biomarkers as surrogates for bloodstream infections.
(2007). Trampuz A: Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulasenegative staphylococci. Infection
(2001). Troillet N: Usefulness of procalcitonin serum level for the diagnosis of bacteremia.
(1992). Wysenbeek AJ: Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med